Rare
lephants
Screener
Toggle theme
Inogen, Inc.
INGN
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2024
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
Total Cash from Operations:
$49.1M
Line Item
Value
% of Total
Capital Expenditures
$0
0.0%
Other Investing
$0
0.0%
Working Capital
$10.3M
21.1%
Other
$12.0M
24.5%
Net Cash Flow
$26.7M
54.5%
Download CSV
